Anti-Human AXL Recombinant Antibody (1613F12) (CAT#: TAB-1093CL)

Figure 1 In vitro cytotoxicity assay using Mab-zap conjugated secondary antibody on SN12C cells.

Figure 2 A, B and C: Binding specificity of 1613F12 on the immobilized rhAxl-Fc protein (A), rhDtk-Fc (B) or rhMer-Fc (C) proteins by ELISA.

Figure 3 FACS analysis of the 1613F12 binding on human tumor cells.

Figure 4 ELISA on the immobilized rmAxl-Fc protein (“rm” for murine recombinant).

Figure 5 1613F12 binding on COS7 cells as determined by indirect labelling protocol using flow cytometry method.

Figure 6 Competition ELISA of Gas6 binding using 1613F12.

Figure 7 Epitope binding analysis by western Blot using SN12C cell lysate.

NH (no heat); NR (no reduction); H (heat); R (reduction). GAPDH detection attests to the correct sample loading on the gel.

Figure 8 Effect of 1613F12 on in vitro SN12C cells proliferation compared to the effect of the mIgG1 isotype control antibody.